San J. Chai
Subang Jaya, Malaysia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The origins, roles and therapies of cancer associated fibroblast in liver cancer.
Journal: Frontiers in oncology
Published: January 26, 2023
DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor.
Journal: Frontiers in immunology
Published: August 23, 2021
An Oncogenic Role for Four-Jointed Box 1 (FJX1) in Nasopharyngeal Carcinoma.
Journal: Disease markers
Published: November 30, 2018
In vitro evaluation of dual-antigenic PV1 peptide vaccine in head and neck cancer patients.
Journal: Human vaccines & immunotherapeutics
Published: September 08, 2018
Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.
Journal: Scientific reports
Published: November 09, 2016
HOPX functions as a tumour suppressor in head and neck cancer.
Journal: Scientific reports
Published: June 21, 2016
Oncogenic effects of WNT5A in Epstein-Barr virus‑associated nasopharyngeal carcinoma.
Journal: International journal of oncology
Published: January 06, 2014
Clinical significance of plasma Epstein-Barr Virus DNA loads in a large cohort of Malaysian patients with nasopharyngeal carcinoma.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: March 05, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026